CVC Limited's push to roll two directors of biotech firm Bionomics and install its own candidates has taken a blow with Bionomics shareholder Private Portfolio Managers saying it does not support the move.

Last week CVC, which owns 5.18 per cent of Bionomics, said it would call an extraordinary general meeting to oust chairman Graeme Kaufman and director Trevor Tappenden from the board.